Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Renalytix Plc

Renalytix Plc (RNLX) Stock Overview

Explore Renalytix Plc’s financial performance, market position, analyst ratings, and future outlook.

RNLX●NASDAQ
HealthcareMedical - Healthcare Information Services
$0.21
$0.01(5.66%)
U.S. Market opens in 63h 24m

Renalytix Plc (RNLX)

Meyka AI Score

Z

Key Financials

Market Cap22.5M
P/E Ratio-0.33
EPS (TTM)$-0.62
ROE-6.31%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

RNLX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Renalytix Plc (NASDAQ: RNLX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Renalytix Plc's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of RNLX on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Renalytix Plc's NASDAQ-traded stock include a P/E ratio of -0.33 and a market capitalization of 22.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of RNLX on the NASDAQ.

Price Performance (NASDAQ: RNLX)

1-Day Change
N/A
5-Day Change
23.86%
1-Month Change
5.66%
3-Month Change
-44.03%
6-Month Change
-69.98%
Year-to-Date (YTD) Change
-51.27%
1-Year Change
-80.09%
3-Year Change
-99.09%
5-Year Change
-98.47%
All-Time (Max) Change
-98.47%

Contact Information

https://renalytix.com
646 397 3970
1460 Broadway, New York City, NY, 10036

Company Facts

1,020 Employees
IPO DateJul 17, 2020
CountryUS

Frequently Asked Questions